Global Vascular

Developer of drug eluting stent delivery system for lower limb artery disease

placeTokyo, Tokyo, Japan calendar_todayFounded 2022 language g-vasc.com

Innovation

3 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 20 times.

YearFilings
20222
20231
20242
20253

Investor mix

10 investors on record; lead investors include Diamond Medino Capital, FTI, Tokyo University of Science Innovation Capital, Mitsubishi UFJ Capital.

Investor typeCountShare
Venture capital550%
Other / undisclosed550%
Coming soon